MILADYS DELGADO: Open Payments
NPI 1194863159 · MULLICA HILL, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,566 in 64 payments from 15 companies in 2025. Trend: 2023 $1,175 · 2024 $1,700 · 2025 $1,566
Food & beverage: $1,566
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 12 | $273 |
| Novartis Pharmaceuticals Corporation | 13 | $242 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 10 | $235 |
| AstraZeneca Pharmaceuticals LP | 5 | $224 |
| E.R. Squibb & Sons, L.L.C. | 6 | $187 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $98 |
| Amgen Inc. | 6 | $94 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $38 |
| PFIZER INC. | 2 | $34 |
| Esperion Therapeutics, Inc. | 2 | $32 |
Products named: JARDIANCE, LEQVIO, Ozempic, LOKELMA, Wegovy, FARXIGA, LifeVest, Repatha.
Industry payments across NJ — which companies pay providers there.
